Opzelura @ Klick Health

In July 2022, the FDA approved Opzelura for use in non-segmental vitiligo. During my contract, I worked on its official launch.

This included: websites, social media posts, web banners, storyboard edits, website file preparations for the development team, and digital and print promotional materials, icon library updates, and colour selections, on both the consumer and healthcare professional (HCP) sides.